PromoterBinding :

Entities PPARA ---- APOA1
References 19
Connectivity 2
Effect unknown
Owner Public
URN urn:agi-PromoterBinding:inout-urn:agi-llid:5465:inout-urn:agi-llid:335::unknown

CellType macrophage
Journal Diabetes
Journal Reference v50 i8 p1851 (2001)
Journal Link http://diabetes.diabetesjournals.org/cgi/content/full/50/8/1851
MedLine Reference 11473048:1155
Sentence Similarly, human apo A-I gene promoter may interact with PPAR- nuclear protein for its transcriptional regulation by fibrates ( 47 ).
Organism Mus musculus

Organ liver
Journal J. Biol. Chem
Journal Reference v278 i40 p38188 (2003)
Journal Link http://www.jbc.org/cgi/content/full/278/40/38188
MedLine Reference 12882972:1165
Sentence Fibrates are widely used hypolipidemic drugs, and they activate PPARalpha that binds to the PPRE element on the human apoA-I promoter and positively regulate the expression of apoA-I.
Organism Mus musculus

Journal ATVB
Journal Reference v21 i3 p372 (2001)
Journal Link http://atvb.ahajournals.org/cgi/content/full/21/3/372
MedLine Reference 11231916:1115
Sentence For example, apoE-knockout mice that overexpress apo A-I, which results in increased HDL levels, are resistant to atherosclerosis. 26 Because the apo A-I gene contains a peroxisome proliferatorA?A?A?responsive element, it is possible that the apo A-I gene is positively regulated by PPAR- in addition to PPAR- agonists. 27 Furthermore, activation of PPAR- upregulates LPL gene expression. 28 29 The increased LPL may stimulate lipolysis of TG-rich lipoproteins, thereby contributing to the elevation of plasma HDL cholesterol levels in apoE-knockout mice, as is the case with LPL-transgenic mice. 23 In addition to favorable changes in plasma lipoprotein metabolism, attenuation of hyperinsulinemic hyperglycemia, a hallmark of the insulin resistance syndrome, may underlie the antiatherogenic effects of troglitazone.
Organism Mus musculus

Organ immunologic
Journal Cell
Journal Reference v104 i4 p503 (2001)
Journal Link http://www.cell.com/cgi/content/full/104/4/503
MedLine Reference 3092358090
Sentence Intriguingly, PPARalpha stimulates expression of apoA-I and raises HDL levels in humans but not rodents due to differences in cis active regulatory elements in the apoA-I promoter (Staels and Auwerx, 1998 ).

Journal Circulation Res
Journal Reference v94 i7 p993 (2004)
Journal Link http://circres.ahajournals.org/cgi/content/full/94/7/993
MedLine Reference 15001527:1124
Sentence PPARA gene expression has been shown to affect the expression of APOA1 , APOC3 , and APOA5 . 44,45 Indeed, variation near the PPARA locus has been shown to have a modifying effect on plasma concentrations of apoC-III in FCH subjects, raising the possibility of an additional effect on plasma apoAV, which could subsequently influence triglyceride levels. 46 Lastly, we were also able to place APOA5 within the context of a previously defined FCH susceptibility haplotype at this locus.

Tissue cardiovascular
Journal Diabetes
Journal Reference v51 i4 p1083 (2002)
Journal Link http://diabetes.diabetesjournals.org/cgi/content/full/51/4/1083
MedLine Reference 11916929:1048
Sentence In humans, the apoA-I gene promoter is under positive control by PPAR- , whereas in rodents, it is negatively regulated by PPAR- .
Organism Mus musculus

Organ liver
Journal J. Biol. Chem
Journal Reference v276 i7 p4634 (2001)
Journal Link http://www.jbc.org/cgi/content/full/276/7/4634
MedLine Reference 11050100:1019
Sentence In contrast, plasma apoA-I and liver apoA-I mRNA levels were decreased in wild-type but not in PPARalpha-deficient mice after fish oil feeding indicating that PPARalpha contributes to the effect of fish oil on apoA-I gene expression.
Organism Mus musculus

Organ heart
Journal J. Biol. Chem
Journal Reference v277 i50 p48051 (2002)
Journal Link http://www.jbc.org/cgi/content/full/277/50/48051
MedLine Reference 12377786:1033
Sentence As in humans, fibrate-activated PPARalpha induces the expression of human apoA-I in transgenic mice overexpressing the human apoA-I (hapoA-I ) gene (hapoA-I Tg), thereby increasing HDL production ( 14 ).
Organism Mus musculus

CellType adipocyte
Journal J. Biol. Chem
Journal Reference v278 i14 p11945 (2003)
Journal Link http://www.jbc.org/cgi/content/full/278/14/11945
MedLine Reference 12551936:1322
Sentence For example, the PPARalpha agonist fenofibrate increases apoA-I expression by 1.5-2.0-fold; yet this translates into a clinically important high density lipoprotein raising effect ( 65 ).

Organ liver
Journal J. Biol. Chem
Journal Reference v272 i43 p27307 (1997)
Journal Link http://www.jbc.org/cgi/content/full/272/43/27307
MedLine Reference 9341179:1147
Sentence This indicates that PPARalpha is one of the key players in determining liver apoA-I expression.
Organism Mus musculus

MedLine Reference 7983038:9
Organism Rattus norvegicus

CellType hepatocyte
Journal ATVB
Journal Reference v16 i8 p1052 (1996)
Journal Link http://atvb.ahajournals.org/cgi/content/full/16/8/1052
MedLine Reference 8696946:1288

Journal Heart Circul
Journal Reference v285 i1 pH1 (2003)
Journal Link http://ajpheart.physiology.org/cgi/content/full/285/1/H1
MedLine Reference 12623780:1392
Organism Mus musculus

Journal Lipid Res
Journal Reference v41 i3 p514 (2000)
Journal Link http://www.jlr.org/cgi/content/full/41/3/514
MedLine Reference 10744771:1419
Organism Rattus norvegicus

Journal Lipid Res
Journal Reference v43 i12 p2172 (2002)
Journal Link http://www.jlr.org/cgi/content/full/43/12/2172
MedLine Reference 12454280:1569
Organism Rattus norvegicus

Tissue thyroid
Journal Lipid Res
Journal Reference v42 i5 p716 (2001)
Journal Link http://www.jlr.org/cgi/content/full/42/5/716
MedLine Reference 11352978:1280

Organ liver
MedLine Reference 9694537:2
Organism Mus musculus

CellType cardiomyocyte
CellLineName FA
Tissue islet
Organ pancreas
Journal Mol. Endocrin
Journal Reference v16 i5 p1013 (2002)
Journal Link http://mend.endojournals.org/cgi/content/full/16/5/1013
MedLine Reference 11981036:1038

Organ liver
Journal J. Biol. Chem
Journal Reference v275 i22 p16638 (2000)
Journal Link http://www.jbc.org/cgi/content/full/275/22/16638
MedLine Reference 10748086:1128